Advanced Filters
noise

Hormone Deficiencies Clinical Trials

A listing of Hormone Deficiencies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 58 clinical trials
D Dr Sehrish Ashraf, FCPS

Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia

Androgenetic alopecia is a common condition affects both genders. Patients of androgenetic alopecia following inclusion criteria will be enrolled after ethical approval and informed consent. Pre-treatment assessment will be done by Physian Global assessment, Patient global assessment and hair density by trichoscopy of areas under treatment. Patients will be categorized …

18 - 70 years of age Both Phase 2

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Randomized, double-blind, vehicle-controlled, parallel group, multi-dose study of TDM-105795 in male subjects with androgenetic alopecia

18 - 55 years of age Male Phase 2
S Susan Riley, CMA, Tech

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

The primary objective of this study is to evaluate the safety and efficacy of the use of a biocellular mixture of emulsified adipose-derived tissue stromal vascular fraction (AD-tSVF) and high density platelet-rich plasma concentrate (HD- PRP). Additionally, comparison with clinical outcomes of adipose-derived cellular Stromal Vascular Fraction (AD-cSVF) + AD-tSVF …

18 - 75 years of age Both Phase N/A
R Raja Sivamani, MD, MS, AP

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

The purpose of this study is to assess how an oral herbal supplement influences hair density, shine, growth, and microbiome.

25 - 65 years of age Female Phase N/A
W Warner Robinson, DMD

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

The purpose of this study is to evaluate hairstyling techniques aimed at increasing efficacy of scalp cooling in the prevention of chemotherapy-induced alopecia, determine scalp cooling effect on persistent chemotherapy-induced alopecia, and elucidate molecular mechanisms and predictive biomarkers associated with scalp cooling success in patients with skin of color receiving …

18 - 100 years of age Both Phase N/A

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

This study will test whether minoxidil taken by mouth (oral minoxidil) can improve hair loss caused by cancer treatment in children and young adults. In addition, the researchers will test the safety of oral minoxidil, and see if the study drug causes few or mild side effects in participants. Other …

6 - 18 years of age Both Phase 2
M Melissa Hines, MD

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

This study is being done to see if the Paxman scalp cooling device can prevent hair loss in pediatric patients receiving chemotherapy for non-cancerous conditions or solid tumors. Primary Objective To assess the safety and feasibility of the use of a scalp cooling device in pediatric and young adult patients …

7 - 100 years of age Both Phase N/A

Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females

A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair.

18 - 70 years of age Female Phase N/A

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

The main purpose of this study is to measure the efficacy of farudodstat compared to placebo at Week 12 from the treatment start, in adult participants with Alopecia Areata (AA) with 30% or greater scalp hair loss.

18 - 100 years of age Both Phase 2
A Alicia Papalia

Regeneron AA Multicenter (Dupilumab)

This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affecting more than 50% of the scalp) at the time of screening with a targeted 54 subjects completers …

18 - 100 years of age Both Phase 2

Rewrite in simple language using AI